Anding, Carmencita .
HRN: 20-49-10 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
CEFTRIAXONE 1G (VIAL)
10/18/2023
10/25/2023
2G
IV
OD
Typhoid Fever
Checking Final Appropriateness
10/19/2023
CEFTRIAXONE 1G (VIAL)
10/19/2023
10/25/2023
IVTT
2 Grams
Q12h
Meningitis
Checking Final Appropriateness
10/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/19/2023
10/25/2023
IVTT
4.5grams
Q8h
Aspiration Pneumonia
Checking Final Appropriateness